Smith D - Search Results

1

Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.

Smith D. Smith D. J Neurol Sci. 2004 Aug 15;223(1):73-9. doi: 10.1016/j.jns.2004.04.026. J Neurol Sci. 2004. PMID: 15261565 Clinical Trial.

2

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H. Smith DR, et al. Mult Scler. 2005 Oct;11(5):573-82. doi: 10.1191/1352458505ms1210oa. Mult Scler. 2005. PMID: 16193896 Clinical Trial.

3

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.

Smith DR, Balashov KE, Hafler DA, Khoury SJ, Weiner HL. Smith DR, et al. Ann Neurol. 1997 Sep;42(3):313-8. doi: 10.1002/ana.410420307. Ann Neurol. 1997. PMID: 9307252

4

Interferon-beta therapy for multiple sclerosis--is the injection site the relevant action site?

Smith D. Smith D. J Neuroimmunol. 2009 Oct 30;215(1-2):117-21. doi: 10.1016/j.jneuroim.2009.08.011. Epub 2009 Sep 20. J Neuroimmunol. 2009. PMID: 19773087 Review.

5

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khoury SJ. Comabella M, et al. Among authors: smith d. J Clin Invest. 1998 Aug 15;102(4):671-8. doi: 10.1172/JCI3125. J Clin Invest. 1998. PMID: 9710434 Free PMC article.

6

Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.

Takashima H, Smith DR, Fukaura H, Khoury SJ, Hafler DA, Weiner HL. Takashima H, et al. Among authors: smith dr. Clin Immunol Immunopathol. 1998 Jul;88(1):28-34. doi: 10.1006/clin.1998.4558. Clin Immunol Immunopathol. 1998. PMID: 9683547

7

Seasonal variation of interferon-gamma production in progressive multiple sclerosis.

Balashov KE, Olek MJ, Smith DR, Khoury SJ, Weiner HL. Balashov KE, et al. Among authors: smith dr. Ann Neurol. 1998 Nov;44(5):824-8. doi: 10.1002/ana.410440519. Ann Neurol. 1998. PMID: 9818941

8

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.

Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. Glass J, et al. Among authors: smith d. J Neurosurg. 1992 May;76(5):741-5. doi: 10.3171/jns.1992.76.5.0741. J Neurosurg. 1992. PMID: 1564535

9

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL. Balashov KE, et al. Among authors: smith dr. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):599-603. doi: 10.1073/pnas.94.2.599. Proc Natl Acad Sci U S A. 1997. PMID: 9012830 Free PMC article.

10

HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.

Smith D, Buckle GJ, Hafler DA, Frank DA, Höllsberg P. Smith D, et al. Virology. 1999 May 10;257(2):314-21. doi: 10.1006/viro.1999.9679. Virology. 1999. PMID: 10329542 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,254 results

Search Page

Filters